Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
25 hedge funds and large institutions have $6.62M invested in Nymox Pharmaceutical Corp in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 9 closing their positions.
0.45% more ownership
Funds ownership: 2.54% → 2.99% (+0.45%)
9% less capital invested
Capital invested by funds: $7.24M → $6.62M (-$619K)
14% less funds holding
Funds holding: 29 → 25 (-4)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
86% less call options, than puts
Call options by funds: $1K | Put options by funds: $7K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$514K |
| 2 |
AIG
American International Group
New York
|
+$123K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$70.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$68K |
| 5 |
MCM
Marathon Capital Management
Hunt Valley,
Maryland
|
+$53.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$324K |
| 2 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
-$117K |
| 3 |
CL
Croft-Leominster
Baltimore,
Maryland
|
-$87K |
| 4 |
WB
Webster Bank
Waterbury,
Connecticut
|
-$86K |
| 5 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$79K |
NYMX Hedge Fund Activity: Q4 2014 in Review
25 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2014, worth a combined $6.62M — down 8.6% from $7.24M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NYMX and 6 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was Advisors Asset Management, adding an estimated $514K. The largest seller was Millennium Management, exiting entirely with an estimated $324K sold.
- 25 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2014, down from 29 in Q3 2014.
- Funds reported $6.62M of Nymox Pharmaceutical Corp stock for Q4 2014, down 8.6% quarter-over-quarter.
- 6 funds opened new Nymox Pharmaceutical Corp positions in Q4 2014 and 9 closed out, a net change of -3 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q4 2014 was Advisors Asset Management, an estimated $514K added.
- The largest Nymox Pharmaceutical Corp seller in Q4 2014 was Millennium Management, an estimated $324K sold.
Based on aggregated 13F filings for Q4 2014.